BevCanna is partnering with Capna Intellectual to bring its leading multi-state cannabis vape brand, Bloom, to Canada
Cannabis stocks were a mixed bag on Wednesday, but the sector as a whole continued to drift lower.
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 0.6% to 136.86 points. One bright spot was the Horizons Marijuana Life Sciences Index ETF, which gained 0.5% to C$10.70, while the OTCQX Cannabis Index sank nearly 2% to 478.4 points.
Buds
() (OTCMKTS:BVNNF) shares rose after the company announced a partnership with cannabis operator Capna Intellectual Inc to bring its leading multi-state cannabis vape brand, Bloom, to Canada.
BevCanna said it will manufacture and sell Bloom-branded products, including cannabis concentrates and extracts.
Its stock increased 4% to C$0.52 on the CSE and 1.3% to US$0.40 on OTC Markets.
Inc (), meanwhile, obtained a licence for cannabis research and development from the Portuguese government.
The company said its fully operational R&D laboratory in Lisbon will now develop cannabis-based products and operate as a pilot-scale refinery for the transformation of cannabis-based ingredients.
Shares rose 4.6% to C$1.15.
() (OTCMKTS:GLDFF) shares did well in the US following the Nevada launch of Chalice Farms Chews, a line of cannabis-infused fruit snacks.
It's share price jumped 20% to US$0.02.
Duds
, which does business as Origin House (CSE:OH) (OTCMKTS:ORHOF), struggled for the third day in a row this week.
The company announced late Tuesday in a joint statement with US cannabis operator Cresco Labs Inc () (OTCMKTS:CRLBF) that the waiting period necessary for Cresco to acquire Origin House had ended and now moves to the next phase. The companies now plan to pursue an acquisition deal.
Origin shares fell 7.6% to C$5.25 in Toronto and 7.4% to US$4.01 in New York.
Other marijuana stocks that struggled to find their footing were Hexo Corp (TSE:HEXO) (), which dropped 2.4% to C$3.31 on Bay Street and 2.3% to US$2.53 on Wall Street; and () (OTCMKTS:SNVF), which declined 4.8% to C$1.38 on the CSE and 3.2% to US$1.05 on OTC Markets.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel